Harbin Pharmaceutical's mixed reform may touch the 'tender offer' exclusive response to prepare for a new journey-News-Tianya Pharmaceutical Network


2022-08-08: [Chinese Article Link]  The introduction of new investors by the Al-Hax Group appears to be a sign that the mixage that has been going on for many years will end, but the issuance of the most recent bulletin seems to be a sign of possible variables in the mix. On the evening of 12 August, Happiness shares issued an announcement stating that the company-owned shareholder Hharma Group Ltd. (`Hharma Group') had introduced Chongqing Harper's equity investment fund partnership (`Jongqing Harper') and Tianjin Black Maroon Investment Management Ltd. (`Black Maroon') as new investors by means of a build-up of equity. It is understood that Chongqing Harper and Black Maroon will inject a combined total of $1,208 million into the HNS. In particular, Chongqing Harper, with cash of $805 million, claims an additional RMB 436 million, representing 10% of HPG’s registered capital after the completion of this replenishment. The new registered capital of the Black Maroon Group, with cash of $403 million, is $218 million, representing 5 per cent of the registered capital of the Group after the completion of the replenishment. Upon completion of the replenishment, the holdings of the Harbin City State Finance Committee will be reduced from 45 per cent to 38.25 per cent, the HAG Board of Directors will be increased from the current five to six members, the HNS Chairman will be elected by a majority of the company's directors and the Chairman will be the statutory representative of the company. The halp group has also transformed state-owned holding companies into state-owned equity companies, which means that the long-outstanding mix of drugs will be back on the ground. On the day the news came out, the halp shares and the people’s share price market reacted positively. On 12 August, the stock price of Hharma was increased by 5.71 per cent on that day and 2.8 per cent on that day between the people and Thailand, indicating the market's certainty that the Hharma road had finally reached a good end. In an interview with the E Pharmacy Manager, Xu Hae-yung, the General Manager of HAG, stated that the core direction of HDU was to supplement strategic resources and further improve market-based corporate governance structures so that HAND could respond quickly to the dramatic changes in the pharmaceutical market in recent years and consolidate its core competitiveness. She added that the pharmaceutical industry was a fully competitive industry and that a fully marketed enterprise could better match markets, respond effectively to rapid changes in the environment and make strategic layout and operational decisions that were consistent with market patterns and industry characteristics. In turn, a combination of ownership reforms by the Al Qaeda Group has helped to attract excellence, build a pool of professional talent, and reward incentives according to market rules. At the same time, pharmaceutical firms maintain their sustained competitiveness through innovation, while the investment in innovation is high-risk, and a fully marketed mechanism can better support innovative inputs. However, on 13 August, Happiness issued another announcement stating that the introduction of two investors in the Replenishment would potentially trigger an offer acquisition, which would require further negotiation among the parties involved in this transfer of equity. There is significant uncertainty as to whether the offer will be implemented, and there are no specific arrangements on the subject and how it will be implemented, and there may be a significant risk that the transfer of equity will not continue if the parties concerned fail to agree on the acquisition of the offer. This means that the halogen mix, which has continued over the course of the 15th, has met with uncertainty at the gate, and has been reflected in a small fall in the share price of the halp and the share price of the people with Thailand, indicating market concerns about this variable. Ongoing communication on offer acquisition According to the management of listed companies issued by the CSRC, there are two cases in which an offer to acquire a listed company may be triggered. First, an offer to acquire all shares in a listed company should be made by an offer to all shareholders of the company, when the buyer holds, controls the shares of a listed company at 30% of the shares that the company has issued. Secondly, all shareholders of a listed company whose shares are to be held and controlled by the acquirer in excess of 30 per cent of the shares issued by the company should be offered to acquire all shares held by the company by means of an offer acquisition. It is worth noting that the two companies involved in this Hharma conversion, Chongqing Harper and Black Maroon, did not have much to do with Hharma previously, in terms of equity structures. According to the public information, Chongqing Harper was established as a partnership on 4 July 2019. The enforcement partner is Harper Investment Consulting (Juhai) LLC (Juhai Harper) and the partner is represented by Chen Ri. The company and another partner, Harbour Pharmaceutical Investment Co. Limited, both established in June 2019, pledged $1.5 billion, but Chongqing Harper had not previously invested abroad. It is worth noting, however, that the company's business partners are represented by Chen Ri, who is also the statutory representative and investment manager of Hae Park Investment Management Limited. The company is currently investing in four enterprises, none of which is related to the pharmaceutical industry. How do they reach the 30 per cent red line for the first or second case of an offer? There are doubts on all sides of the market, and the HNS management team, in an interview with the E Pharmacy Manager, has indicated that the offer acquisition is being communicated with the submission on an ongoing basis. 02. Entry of career managers While there are more variables to the process of drug amalgamation in equity structure arrangements, medicines are well prepared for new business alternatives in personnel and business development arrangements. On 4 March 2019, the Al-Hadis Group issued a circular stating that, after consideration by the company's board of directors, it had decided to hire Ms. Xu Hae-yeong as the company's general manager, and that, upon nomination by the general manager, Ms. Xu Hae-yung, the company's board of directors had decided to hire Mr. Liu Ming and Mr. Shaw Qiang as the company's deputy general manager. The decision to introduce the three new managers, all of whom had extensive experience in the commercial management of medicines in foreign pharmaceutical companies, had attracted market interest once announced. According to the data, Xu Hae-yeong was born in 1967, a Bachelor of Economics from Beijing University and a Master of International Finance from Beijing University. He was President of the Novartis Group, Director General of the National Investment and Innovation Management Corporation, Director of Operations of the Great Health Industry Department of the Chamber of Commerce and Industry Group, and Managing Director of the Health Industry Investment Corporation of the Chamber of Commerce and Industry Group. Liu was born in 1971, a Bachelor of Science from Zhejiang Medical University, and a Master of Science from the Central European Institute of International Business. He was Director-General of the immune rheumatism department of the Chinese company Yape, and President of the Chinese District of Lan Sheng Medicine Group. She was born in 1970, Bachelor of Arts in Economics, People's University of China, Master of Business Administration, Kellogg Business School, Northwestern University of the United States, and Doctor of Economics, International University of Florida, United States of America. He was Director-General of the Pharmacy Industry Advisory Operations, and Managing Director of the Strategic Development Department, Health Department, Group of Business Bureaus. Xu Hae-yeong, in an interview, said that with the support of the Board of Directors, HNS management had recently been significantly strengthened, with a group of industry elites joining the HNS, mainly doing a few things: strengthening the marketing system, sorting out product lines, reshaping brand influence, and optimizing management systems on the basis of ERP. On 14 February 2018, HNS announced a strategic collaboration with the global top health nutrition brand of the United States, with $300 million to buy 40% of its shares, and became the single largest shareholder of the GNC’s listed company and the only distributor in the Chinese region. The GNP product lines cover more than a dozen varieties of child nutrition, maternal nutrition, improved sleep, weight management, etc. The price range for products varies from 100 Yuan to 1,000 yuan, depending on the user's needs. In October 2018, Hharma shares signed an authorization and distribution agreement with Tiva Pharmaceutical Industries Ltd., a well-known pseudo-pharmaceutical company, to obtain approvals and import authorizations in China for six products such as hydrazine sulphate and exclusive sales agents in China for 20 years, and to carry out work related to the transfer of production technology. There is no doubt that H2P has reached the critical threshold of transition. From 2014 to 2018, H2P was on the decline in performance, and the rate of decline ranged from one to two digits. In 2018, HDR 10,814 million was earned throughout the year, a decrease of 10.02 per cent in the same year and $346 million in net profits attributable to shareholders in listed companies, a decline of 14.95 per cent in the same year. In 2019, HAG experienced significant changes in its mix of personnel, operations and equity, with HPD achieving operating income of $11.6 billion in 2019, while increasing the profitability of its main products and seeking and nurturing new profit growth points. Can these goals be achieved in the light of new changes, and can Hharma successfully complete its business transformation?


Note: This is a machine translated version of the Chinese news media article. A mature and nuanced reading is suggested.




Trending Topics


Trending News

What China Reads


Harbin Pharmaceutical's mixed reform may touch the 'tender offer' exclusive response to prepare for a new journey-News-Tianya Pharmaceutical Network


2022-08-08: [Article Link]  The introduction of new investors by the Al-Hax Group appears to be a sign that the mixage that has been going on for many years will end, but the issuance of the most recent bulletin seems to be a sign of possible variables in the mix. On the evening of 12 August, Happiness shares issued an announcement stating that the company-owned shareholder Hharma Group Ltd. (`Hharma Group') had introduced Chongqing Harper's equity investment fund partnership (`Jongqing Harper') and Tianjin Black Maroon Investment Management Ltd. (`Black Maroon') as new investors by means of a build-up of equity. It is understood that Chongqing Harper and Black Maroon will inject a combined total of $1,208 million into the HNS. In particular, Chongqing Harper, with cash of $805 million, claims an additional RMB 436 million, representing 10% of HPG’s registered capital after the completion of this replenishment. The new registered capital of the Black Maroon Group, with cash of $403 million, is $218 million, representing 5 per cent of the registered capital of the Group after the completion of the replenishment. Upon completion of the replenishment, the holdings of the Harbin City State Finance Committee will be reduced from 45 per cent to 38.25 per cent, the HAG Board of Directors will be increased from the current five to six members, the HNS Chairman will be elected by a majority of the company's directors and the Chairman will be the statutory representative of the company. The halp group has also transformed state-owned holding companies into state-owned equity companies, which means that the long-outstanding mix of drugs will be back on the ground. On the day the news came out, the halp shares and the people’s share price market reacted positively. On 12 August, the stock price of Hharma was increased by 5.71 per cent on that day and 2.8 per cent on that day between the people and Thailand, indicating the market's certainty that the Hharma road had finally reached a good end. In an interview with the E Pharmacy Manager, Xu Hae-yung, the General Manager of HAG, stated that the core direction of HDU was to supplement strategic resources and further improve market-based corporate governance structures so that HAND could respond quickly to the dramatic changes in the pharmaceutical market in recent years and consolidate its core competitiveness. She added that the pharmaceutical industry was a fully competitive industry and that a fully marketed enterprise could better match markets, respond effectively to rapid changes in the environment and make strategic layout and operational decisions that were consistent with market patterns and industry characteristics. In turn, a combination of ownership reforms by the Al Qaeda Group has helped to attract excellence, build a pool of professional talent, and reward incentives according to market rules. At the same time, pharmaceutical firms maintain their sustained competitiveness through innovation, while the investment in innovation is high-risk, and a fully marketed mechanism can better support innovative inputs. However, on 13 August, Happiness issued another announcement stating that the introduction of two investors in the Replenishment would potentially trigger an offer acquisition, which would require further negotiation among the parties involved in this transfer of equity. There is significant uncertainty as to whether the offer will be implemented, and there are no specific arrangements on the subject and how it will be implemented, and there may be a significant risk that the transfer of equity will not continue if the parties concerned fail to agree on the acquisition of the offer. This means that the halogen mix, which has continued over the course of the 15th, has met with uncertainty at the gate, and has been reflected in a small fall in the share price of the halp and the share price of the people with Thailand, indicating market concerns about this variable. Ongoing communication on offer acquisition According to the management of listed companies issued by the CSRC, there are two cases in which an offer to acquire a listed company may be triggered. First, an offer to acquire all shares in a listed company should be made by an offer to all shareholders of the company, when the buyer holds, controls the shares of a listed company at 30% of the shares that the company has issued. Secondly, all shareholders of a listed company whose shares are to be held and controlled by the acquirer in excess of 30 per cent of the shares issued by the company should be offered to acquire all shares held by the company by means of an offer acquisition. It is worth noting that the two companies involved in this Hharma conversion, Chongqing Harper and Black Maroon, did not have much to do with Hharma previously, in terms of equity structures. According to the public information, Chongqing Harper was established as a partnership on 4 July 2019. The enforcement partner is Harper Investment Consulting (Juhai) LLC (Juhai Harper) and the partner is represented by Chen Ri. The company and another partner, Harbour Pharmaceutical Investment Co. Limited, both established in June 2019, pledged $1.5 billion, but Chongqing Harper had not previously invested abroad. It is worth noting, however, that the company's business partners are represented by Chen Ri, who is also the statutory representative and investment manager of Hae Park Investment Management Limited. The company is currently investing in four enterprises, none of which is related to the pharmaceutical industry. How do they reach the 30 per cent red line for the first or second case of an offer? There are doubts on all sides of the market, and the HNS management team, in an interview with the E Pharmacy Manager, has indicated that the offer acquisition is being communicated with the submission on an ongoing basis. 02. Entry of career managers While there are more variables to the process of drug amalgamation in equity structure arrangements, medicines are well prepared for new business alternatives in personnel and business development arrangements. On 4 March 2019, the Al-Hadis Group issued a circular stating that, after consideration by the company's board of directors, it had decided to hire Ms. Xu Hae-yeong as the company's general manager, and that, upon nomination by the general manager, Ms. Xu Hae-yung, the company's board of directors had decided to hire Mr. Liu Ming and Mr. Shaw Qiang as the company's deputy general manager. The decision to introduce the three new managers, all of whom had extensive experience in the commercial management of medicines in foreign pharmaceutical companies, had attracted market interest once announced. According to the data, Xu Hae-yeong was born in 1967, a Bachelor of Economics from Beijing University and a Master of International Finance from Beijing University. He was President of the Novartis Group, Director General of the National Investment and Innovation Management Corporation, Director of Operations of the Great Health Industry Department of the Chamber of Commerce and Industry Group, and Managing Director of the Health Industry Investment Corporation of the Chamber of Commerce and Industry Group. Liu was born in 1971, a Bachelor of Science from Zhejiang Medical University, and a Master of Science from the Central European Institute of International Business. He was Director-General of the immune rheumatism department of the Chinese company Yape, and President of the Chinese District of Lan Sheng Medicine Group. She was born in 1970, Bachelor of Arts in Economics, People's University of China, Master of Business Administration, Kellogg Business School, Northwestern University of the United States, and Doctor of Economics, International University of Florida, United States of America. He was Director-General of the Pharmacy Industry Advisory Operations, and Managing Director of the Strategic Development Department, Health Department, Group of Business Bureaus. Xu Hae-yeong, in an interview, said that with the support of the Board of Directors, HNS management had recently been significantly strengthened, with a group of industry elites joining the HNS, mainly doing a few things: strengthening the marketing system, sorting out product lines, reshaping brand influence, and optimizing management systems on the basis of ERP. On 14 February 2018, HNS announced a strategic collaboration with the global top health nutrition brand of the United States, with $300 million to buy 40% of its shares, and became the single largest shareholder of the GNC’s listed company and the only distributor in the Chinese region. The GNP product lines cover more than a dozen varieties of child nutrition, maternal nutrition, improved sleep, weight management, etc. The price range for products varies from 100 Yuan to 1,000 yuan, depending on the user's needs. In October 2018, Hharma shares signed an authorization and distribution agreement with Tiva Pharmaceutical Industries Ltd., a well-known pseudo-pharmaceutical company, to obtain approvals and import authorizations in China for six products such as hydrazine sulphate and exclusive sales agents in China for 20 years, and to carry out work related to the transfer of production technology. There is no doubt that H2P has reached the critical threshold of transition. From 2014 to 2018, H2P was on the decline in performance, and the rate of decline ranged from one to two digits. In 2018, HDR 10,814 million was earned throughout the year, a decrease of 10.02 per cent in the same year and $346 million in net profits attributable to shareholders in listed companies, a decline of 14.95 per cent in the same year. In 2019, HAG experienced significant changes in its mix of personnel, operations and equity, with HPD achieving operating income of $11.6 billion in 2019, while increasing the profitability of its main products and seeking and nurturing new profit growth points. Can these goals be achieved in the light of new changes, and can Hharma successfully complete its business transformation?

Note: This is a translated version of the Chinese news media article. A mature and nuanced reading is suggested.

Recent related articles

Pharmaceutical company executives change blood! More than 250 people left during the year, and the post-95s succeeded the heads of hundreds of billions of pharmaceutical companies

2022-09-26: Image source: Imagine In one day, the old Chinese pharmaceutical company (600771.SH) announced the resignation of several executives. On the evening of 23 September, the Board of Trustees received a written resignation report from the Vice-Chairman, Li Xiaojun, who, for reasons of service,…  

Summary of weekend news: the momentum of the real estate bubble has been substantially reversed, and the China Banking and Insurance Regulatory Commission has released an important signal

2022-09-25: Among the important information that has affected the market this weekend are the following: substantial reversal of the trend of financial bubbles in real estate and the recent release of important signals by the Silver Insurance Supervisory Board; the Central Bank's report that it will increase…  

These important news over the weekend may affect the stock market (with new stock calendar + institutional strategy)

2022-09-25: Macro. Highlights. German Chancellor Scholtz's trip to Saudi Arabia to open the Gulf seeking enhanced cooperation in energy supply In the afternoon of 24 local time, German Chancellor Scholz arrived in Jeddah, the western city of Saudi Arabia, opening a visit to Saudi Arabia, the United Arab…  

Zao Cai 丨 Shanghai liberalizes the "street stall economy": no longer a complete ban on roadside stalls; iPhone 14 sales data for a week is exposed; Putin signs a blockbuster law; the US moon landing rocket launch is postponed again

2022-09-25: No.19 On 24 September, the Global Wealth Management Forum was held at its autumn 2022 summit. The President of the Global Wealth Management Forum and the former Minister of Finance, Wei Wei, said that China remained steadfast in its support for globalization and in its integration and advancement.…  

Zao Finance丨BYD calls the police! The official seal and Wang Chuanfu's signature were forged; the former general manager of Nuo An Fund was investigated; the whole family can also settle down in rented houses! A mega city zooms in; 37-year-old once again pushes the limits of humanity

2022-09-26: NBD Editor Jang Xiaobo Wang No.1 The election of the party’s twenty-largest representatives has been successfully completed under the strong central leadership of the party, with Comrade Xi Jinping at its core. No.2 On 24 September, news of “a number of mega-cities leaving their homes open”…

Zao Cai 丨 BYD called the police; renting a house can also be settled with the whole family, and a mega city is expanding its recruitment; the former general manager of Lion Fund was investigated; at the age of 37, he once again broke the limit of human beings

2022-09-26: NBD Reporter Chan Chan NBD Editor Wang Xiaobo Ho Peach No.1 The election of the party’s twenty-largest representatives has been successfully completed under the strong central leadership of the party, with Comrade Xi Jinping at its core. No.2 On 24 September, news of “a number of mega-cities…

The State-owned Assets Supervision and Administration Commission of the State Council exposed 528 fake central enterprises: fake materials and false affiliations

2022-09-25: Original title: 528 pseudo-state companies exposed by the State Council's State Finance Committee The State Finance Committee of the State Council launched a new “false wave”, and since the announcement of the first 353 counterfeiting companies in October last year, a second batch of counterfeit…

Recent related articles

Pharmaceutical company executives change blood! More than 250 people left during the year, and the post-95s succeeded the heads of hundreds of billions of pharmaceutical companies

2022-09-26: Image source: Imagine In one day, the old Chinese pharmaceutical company (600771.SH) announced the resignation of several executives. On the evening of 23 September, the Board of Trustees received a written resignation report from the Vice-Chairman, Li Xiaojun, who, for reasons of service,…  

Summary of weekend news: the momentum of the real estate bubble has been substantially reversed, and the China Banking and Insurance Regulatory Commission has released an important signal

2022-09-25: Among the important information that has affected the market this weekend are the following: substantial reversal of the trend of financial bubbles in real estate and the recent release of important signals by the Silver Insurance Supervisory Board; the Central Bank's report that it will increase…  

These important news over the weekend may affect the stock market (with new stock calendar + institutional strategy)

2022-09-25: Macro. Highlights. German Chancellor Scholtz's trip to Saudi Arabia to open the Gulf seeking enhanced cooperation in energy supply In the afternoon of 24 local time, German Chancellor Scholz arrived in Jeddah, the western city of Saudi Arabia, opening a visit to Saudi Arabia, the United Arab…  

Zao Cai 丨 Shanghai liberalizes the "street stall economy": no longer a complete ban on roadside stalls; iPhone 14 sales data for a week is exposed; Putin signs a blockbuster law; the US moon landing rocket launch is postponed again

2022-09-25: No.19 On 24 September, the Global Wealth Management Forum was held at its autumn 2022 summit. The President of the Global Wealth Management Forum and the former Minister of Finance, Wei Wei, said that China remained steadfast in its support for globalization and in its integration and advancement.…  

Zao Finance丨BYD calls the police! The official seal and Wang Chuanfu's signature were forged; the former general manager of Nuo An Fund was investigated; the whole family can also settle down in rented houses! A mega city zooms in; 37-year-old once again pushes the limits of humanity

2022-09-26: NBD Editor Jang Xiaobo Wang No.1 The election of the party’s twenty-largest representatives has been successfully completed under the strong central leadership of the party, with Comrade Xi Jinping at its core. No.2 On 24 September, news of “a number of mega-cities leaving their homes open”…

Zao Cai 丨 BYD called the police; renting a house can also be settled with the whole family, and a mega city is expanding its recruitment; the former general manager of Lion Fund was investigated; at the age of 37, he once again broke the limit of human beings

2022-09-26: NBD Reporter Chan Chan NBD Editor Wang Xiaobo Ho Peach No.1 The election of the party’s twenty-largest representatives has been successfully completed under the strong central leadership of the party, with Comrade Xi Jinping at its core. No.2 On 24 September, news of “a number of mega-cities…

The State-owned Assets Supervision and Administration Commission of the State Council exposed 528 fake central enterprises: fake materials and false affiliations

2022-09-25: Original title: 528 pseudo-state companies exposed by the State Council's State Finance Committee The State Finance Committee of the State Council launched a new “false wave”, and since the announcement of the first 353 counterfeiting companies in October last year, a second batch of counterfeit…